BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5664817)

  • 1. [The syndrome of metastazing carcinoid. 3. Long-term follow up of 5-hydroxyindoleacetic acid excretion in the urine].
    Simon J; Láhn V; Opatrný K; Sova J; Sídlová A; Cerhová M; Hůla J; Virt S
    Cas Lek Cesk; 1968 Mar; 107(13):394-8. PubMed ID: 5664817
    [No Abstract]   [Full Text] [Related]  

  • 2. [Excretion of 5-hydroxyindoleacetic acid in carcinoid syndrome].
    Opatrný K; Láhn V; Sova J; Simon J; Virt S; Schwartz A; Levý J
    Z Gesamte Inn Med; 1968 Sep; 23(18):553-6. PubMed ID: 5710484
    [No Abstract]   [Full Text] [Related]  

  • 3. Normal 5-hydroxyindole excretion in the presence of carcinoid syndrome.
    Wiles P; Hampton K; Dean H; Feely M
    Ir Med J; 1987 Apr; 80(4):122-3. PubMed ID: 2439475
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urinary 5-HIAA stimulation test for the diagnosis of carcinoid syndrome caused by carcinoid tumors of the middle intestine].
    Varas MJ; Navarro MA; Rosell P; García F
    Rev Esp Enferm Apar Dig; 1986 Oct; 70(4):311-5. PubMed ID: 2431444
    [No Abstract]   [Full Text] [Related]  

  • 5. The incidence of elevations in urine 5-hydroxyindoleacetic acid.
    Nuttall KL; Pingree SS
    Ann Clin Lab Sci; 1998; 28(3):167-74. PubMed ID: 9646859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of carcinoid syndrome with ocreotide (SMS-201-995)].
    Rodríguez-García JL; Arechaga S; Fraile G; Serrano M
    Rev Clin Esp; 1992 Jul; 191(3):168. PubMed ID: 1380173
    [No Abstract]   [Full Text] [Related]  

  • 7. [Carcinoid syndrome in primary esophageal tumor].
    Broicher K; Hienz HA
    Z Gastroenterol; 1974 Sep; 12 Suppl(0):377-84. PubMed ID: 4418379
    [No Abstract]   [Full Text] [Related]  

  • 8. 'Sweet Dreams', 'Happy Days' and elevated 24-h urine 5-hydroxyindoleacetic acid excretion.
    Hallin ML; Mahmoud K; Viswanath A; Gama R
    Ann Clin Biochem; 2013 Jan; 50(Pt 1):80-2. PubMed ID: 23086978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laboratory findings in the carcinoid syndrome].
    Kähler HJ
    Dtsch Med Wochenschr; 1968 May; 93(19):959-61. PubMed ID: 5300909
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of carcinoid syndrome and urolithiasis. Accidental coincidence or etiological connection].
    Myklebost A
    Tidsskr Nor Laegeforen; 1969 Nov; 89(22):1731-2. PubMed ID: 5382029
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
    Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J
    Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bronchial carcinoid and carcinoid syndrome].
    Biriukov IuV; Bassalyk LS; Kulikov LS; Men'shikov VV; Efimov BI
    Sov Med; 1970 Dec; 33(12):39-43. PubMed ID: 5516942
    [No Abstract]   [Full Text] [Related]  

  • 13. [Carcinoid and carcinoid syndrome].
    Vrubel F; Martínek K
    Cesk Gastroenterol Vyz; 1970 Oct; 24(7):286-90. PubMed ID: 5480235
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of melphalan in the malignant carcinoid syndrome.
    Lotito CA; Mengel CE
    Arch Intern Med; 1969 Jul; 124(1):36-8. PubMed ID: 5791484
    [No Abstract]   [Full Text] [Related]  

  • 15. [The enterochromaffin system and clinical consequences of hyperserotonism].
    Kojecký Z; Kodousek R
    Z Gesamte Inn Med; 1971 Mar; 26(5):Suppl:33-6. PubMed ID: 5560777
    [No Abstract]   [Full Text] [Related]  

  • 16. Case report--carcinoid syndrome: two case reports from reserve unit.
    Smith DF
    J R Nav Med Serv; 2011; 97(2):66-71. PubMed ID: 22013639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical assessment of niacin deficiency among carcinoid cancer patients.
    Shah GM; Shah RG; Veillette H; Kirkland JB; Pasieka JL; Warner RR
    Am J Gastroenterol; 2005 Oct; 100(10):2307-14. PubMed ID: 16181385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 5-dydroxyindolylacetic acid in the colorimetric determination of urinary vanilmandelic acid.
    Fleisher M; Dollinger MR; Schwartz MK
    Am J Clin Pathol; 1969 May; 51(5):555-8. PubMed ID: 5779402
    [No Abstract]   [Full Text] [Related]  

  • 19. The carcinoid syndrome--a role for hemodialysis.
    Creagan ET; Tyce GM; Moertel CG
    Cancer Treat Rep; 1977; 61(1):107-8. PubMed ID: 861959
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of somatostatin infusion in four patients with malignant carcinoid syndrome.
    Quatrini M; Basilisco G; Conte D; Bozzani A; Bardella MT; Bianchi PA
    Am J Gastroenterol; 1983 Mar; 78(3):149-51. PubMed ID: 6187212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.